-PTI/ The Hindu They were told to ramp up supply for medical purposes Ghaziabad: With the COVID-19 surge continuing unabated, the district administration here on Friday asked manufacturers to halt production of industrial-use oxygen and ramp up the supply for medical purposes, officials said. District Magistrate Ajay Shankar Pandey said the administration also asked all hospital in the city to not deny treatment to a COVID-19 patients even if they have no beds....

-The Hindu They seek waiver on some provisions of world agreements that regulate intellectual property rights to expedite steps to contain pandemic India and South Africa, in a formal submission to the World Trade Organization (WTO) on October 2, sought a waiver on certain provisions of the international agreements that regulate intellectual property rights to speed up efforts to prevent, treat and contain the COVID-19 pandemic. In the communication, the countries said there...

-The Hindu The policy has absolutely no consideration for Group 3 patients who require lifelong treatment support, say organisations Caregivers to patients with ‘rare diseases’ and affiliated organisations are dissatisfied with the National Policy for Rare Diseases, 2021 announced on Wednesday. Though the document specifies increasing the government support for treating patients with a ‘rare disease’— from ₹15 lakh to ₹20 lakh — caregivers say this doesn’t reflect actual costs of treatment. There...

-The Indian Express The state must prioritise removing malnutrition, give uncompromising priority to improving primary health infrastructure In 1947, post-colonial India set off with the ambition of building a modern state on the principles of equality where citizens, by virtue of their birth in the country, would be entitled to a life of dignity. While the Constitution provided the rights to life, liberty, nutritional standards and maternity care, it did not explicitly...

-PTI/ Livemint.com * Being Health Minister of the country, how justified is it to release such falsely fabricated unscientific product, the IMA statement said * The IMA statement further said: Can you clarify the time frame, time line for the so-called clinical trial of this said anti-corona product The Indian Medical Association (IMA) on Monday said that it shocked over Patanjali Ayurveda's "blatant lie of WHO certification" for Coronil tablet, which the company...